Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) EPS (Basic) (2020 - 2026)

Cresco Labs filings provide 7 years of EPS (Basic) readings, the most recent being -$0.01 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 81.73% to -$0.01 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.11, a 12.99% decrease, with the full-year FY2025 number at -$0.38, down 72.73% from a year prior.
  • EPS (Basic) hit -$0.01 in Q1 2026 for Cresco Labs, up from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $304233.3 in Q1 2022 to a low of -$96721.4 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was -$0.03 (2024), compared with a mean of $12186.4.
  • The widest YoY moves for EPS (Basic): up 108.16% in 2023, down 5964800.93% in 2023.
  • Cresco Labs' EPS (Basic) stood at -$0.1 in 2022, then skyrocketed by 108.16% to $0.01 in 2023, then tumbled by 59.17% to $0.0 in 2024, then tumbled by 1591.36% to -$0.05 in 2025, then soared by 84.8% to -$0.01 in 2026.
  • The last three reported values for EPS (Basic) were -$0.01 (Q1 2026), -$0.05 (Q4 2025), and -$0.01 (Q3 2025) per Business Quant data.